ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Oncology Institute of Southern Switzerland (IOSI) at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Oncology Institute of Southern Switzerland (IOSI) takes part in 7 sessions at ESMO 2026 in Madrid. Its program focuses on treatment choices and long-term outcomes in prostate and ovarian cancer. Topics include treatment combinations after prostate cancer progresses and care for ovarian cancer with a BRCA mutation.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
Cancer institute of the Ticino public cantonal hospital network, based in Bellinzona, Switzerland.
Talk
Fri Oct 23
16:15–17:15
Learning from setbacks: Redefining success in oncology
YO Vesalius Talk · with Institut Strauss, Memorial Sloan Kettering Cancer Center
Satellite
Fri Oct 23
18:50–19:15
Navigating long-term survival in dMMR/MSI-H EC: The clinicians’ experience
GSK - From evidence to clinical practice: Long-term survival outcomes in advanced endometrial cancer
Gynaecological cancers
Satellite
Fri Oct 23
19:15–19:40
Mapping change: Evolving clinical practice and conversations
GSK - From evidence to clinical practice: Long-term survival outcomes in advanced endometrial cancer · with NYU Langone Perlmutter Cancer Center, Hospital Universitario 12 de Octubre
Gynaecological cancers
Chair
Sat Oct 24
10:15–11:45
Proffered paper: Genitourinary tumours, prostate, penile and testis
with The University of Adelaide
Genitourinary cancers
Abstract
Sat Oct 24
10:35–10:47
Invited Discussant 2215O and 2216O
Proffered paper: Genitourinary tumours, prostate, penile and testis
Genitourinary cancers
Talk
Sat Oct 24
11:51–11:58
Table 4
Mentor the Mentor session
Abstract
Sat Oct 24
17:54–18:06
Invited Discussant LBA4
Presidential Symposium I
Lung & thoracic cancersMelanoma & skin cancersGenitourinary cancers
Satellite
Sun Oct 25
18:55–19:10
What Pathways Are Possible? Evaluating the Evidence Surrounding Combination Strategies in mCRPC
PeerVoice - Navigating the Changing Landscape of 10 mCRPC Management: Reviewing Roads Travelled and Exploring Emerging Directions
Genitourinary cancers
Satellite
Sun Oct 25
19:10–19:30
Placing Data into Practice: What Constitutes Contemporary Best Practice Approaches Upon Progression to mCRPC?
PeerVoice - Navigating the Changing Landscape of 10 mCRPC Management: Reviewing Roads Travelled and Exploring Emerging Directions · with Cliniques universitaires Saint-Luc, Europa Uomo
Genitourinary cancers
Satellite
Sun Oct 25
19:30–19:45
Partnering With Our Patients Across Their mCRPC Journey: Considerations Beyond Initial Treatment Selection
PeerVoice - Navigating the Changing Landscape of 10 mCRPC Management: Reviewing Roads Travelled and Exploring Emerging Directions · with Cliniques universitaires Saint-Luc, Europa Uomo
Genitourinary cancers
Satellite
Sun Oct 25
19:45–19:55
Questions and Answers Session: Expert Insights for Your Compelling Questions
PeerVoice - Navigating the Changing Landscape of 10 mCRPC Management: Reviewing Roads Travelled and Exploring Emerging Directions · with Cliniques universitaires Saint-Luc, Europa Uomo
Genitourinary cancers
Talk
Mon Oct 26
10:15–10:20
Presentation of case/condition
Optimal management of high-grade serous ovarian cancer with BRCA mutation
Gynaecological cancers
Talk
Mon Oct 26
11:00–11:20
Systemic therapy for recurrent BRCAmut HGSOC during PARPi
Optimal management of high-grade serous ovarian cancer with BRCA mutation
Gynaecological cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Oncology Institute of Southern Switzerland (IOSI)

Tell us what you sell and we’ll find the people at Oncology Institute of Southern Switzerland (IOSI) most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction